• 13 November 2016

    The joint EBOVAC1 and EBOVAC2 annual meeting took place in Windsor, UK from 14-16 November 2016.

  • 22 April 2016

    EBOVAC1 has published their first report on Phase 1 data in the April 19th 2016 issue of JAMA

    Press release and more information

  • 04 April 2016

    The first subject was vaccinated on 30 March 2016 at the University of Nairobi, Kenya

  • 29 March 2016

    The 1st EBOVAC2 Newsletter is available!

  • 29 February 2016

    The first subject was randomized on 10 December 2016 at Makerere University in Uganda.

  • 29 February 2016

    The first subject was randomized at CHU Treichville in Côte d'Ivoire on 26 February 2016.

  • 11 February 2016

    The first subject was randomized at the Centre Muraz, Burkina Faso on the 11th of February 2016.

  • 11 February 2016

    EBOVAC2 and the 7 other IMI-funded Ebola+ attended the Cross-topic EbolA+ meeting organised by IMI on 2 February 2016.

  • 11 February 2016

    The EBOVAC1 & EBOVAC2 joint annual meetings were held in Paris on 20-22 January 2016.

  • 16 December 2015

    The first French subjects were randomized in France on 9 December 2015 at Cochin Hospital and on the 10 December at Henri Mondor Hospital in France.

  • 09 December 2015

    To find out more about Inserm's EBOVAC2 campaign to recruit volunteers for trials to test the vaccine against the Ebola virus (in French):

    http://www.recherche-vaccinebola.fr/

    Watch the video on Inserm's EBOVAC2 campaign (in French)

  • 09 December 2015

    Inserm is recruiting 300 volunteers to test the Ebola vaccine virus as part of Phase 2 trials. For more information, see the press release here

  • 09 November 2015

    The first volunteer was screened in France on 4 November 2015. More information coming soon.

  • 16 July 2015

    The University of Oxford has started enrolling volunteers into Phase 2 trials. For more information, click here.

  • 10 June 2015

    EBOVAC1 and EBOVAC2 presented a poster on both projects at Targeting Ebola in Paris, France, 28-29 May 2015.

    To view the poster, click here.

    Rodolphe Thiébaut, EBOVAC2 coordinator (Inserm), made a presentation on accelerated development of Ebola vaccines. More information.

  • 28 May 2015

    The EBOVAC2 website was launched! 

  • 28 May 2015

    The EBOVAC2 grant agreement between IMI2 and Inserm was signed on the 6th of March 2015.

  • Ebola: background

    What is Ebola?

  • Phase 2 trials

    Find out more about EBOVAC2 trials

  • Work programme

    EBOVAC2 is organised into 6 workpackages (WP)

  • Ebola+ programme

    Contributes to efforts to tackle a wide range of challenges in Ebola research